Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
AMARIN CORP PLC\UK (AMRN)
Standardized SEC financial data for AMARIN CORP PLC\UK — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000897448 · NASDAQ · Pharmaceutical Preparations.
Gross margin
56.6%
Operating margin
-23.5%
Net margin
-18.2%
Revenue growth (YoY)
-6.5%
Return on equity
-8.4%
ROIC
-12.2%
Free cash flow
$6.5M
Debt / equity
0.00×
Ratios for fiscal year 2025, standardized from SEC filings.